Veklury is the first approved antiviral agent now for extended pediatric use and for those patients who are suffering in all stages of renal disease
Veklury, a SARS-CoV-2 nucleotide analog RNA polymerase inhibitor, was approved by FDA for the treatment COVID-19 in adults and pediatric
